In vitro activity of L-627, a new carbapenem.
The in vitro activity of L-627, a new parenterally administered carbapenem, was compared with those of imipenem, meropenem, FCE 22101 (a penem), ceftazidime, and ceftriaxone. L-627 was active against members of the family Enterobacteriaceae (MIC for 90% of strains tested [MIC90] ranging from 0.03 to...
Gardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1992
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC192211/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1416883/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.9.1928 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|